Acutaas Chemicals logo

Acutaas Chemicals financials and balance sheet

NSE: ACUTAASBSE: 543349Pharmaceuticals & BiotechnologySmall Cap

Formerly Ami Organics
Last close ₹3,137.70down ₹77.60 (2.41%)BSE ₹3,138.55

Share price at the NSE close on 23 Oct 2026. Previous close ₹3,215.30.

52-week range of traded prices to 23 Oct 2026
₹1,570.00Low, 21 Jan 2026₹3,740.00High, 6 Jul 2026
Market cap
₹25,689 Cr347th largest listed
P/E
66.5
P/B
15.5
Dividend yield
0.08%
ROE
26.1%
ROCE
29.1%
Debt to equity
0.02
Volume, NSE
3,48,10955.1% delivered

5 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Acutaas Chemicals annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹1,339 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue1,339
  2. Materials and goods−566
  3. Employee costs−118
  4. Other expenses−175
  5. Operating profit480
  6. Depreciation−36
  7. Other income+42
  8. One-off items0.0
  9. Finance costs−3.3
  10. Profit before tax483
  11. Tax−126
  12. Net profit356

What the company owns

  • Plant, investments and other assets₹1,165 Cr
  • Receivables₹363 Cr
  • Inventory₹231 Cr
  • Cash and bank₹225 Cr

What pays for it: net worth and liabilities

  • Net worth₹1,711 Cr
  • Owed to suppliers₹154 Cr
  • Other liabilities₹93 Cr
  • Borrowings₹26 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Acutaas Chemicals quarterly results

₹ croreMar 2022Filed 20 MayMar 2023Filed 15 MayMar 2024Filed 13 MayMar 2025Filed 10 JunMar 2026Filed 30 Apr
Revenue from operations5206177171,0071,339
415494589775859
Materials and goods bought273331412552566
Employee costs41496384118
Other expenses101114114139175
Operating profit before depreciation105123128232480
Operating margin20.2%19.9%17.9%23.0%35.9%
Materials, % of revenue52.5%53.7%57.4%54.8%42.3%
Employee costs, % of revenue8.0%7.9%8.8%8.3%8.8%
Other expenses, % of revenue19.4%18.5%15.9%13.8%13.1%
Depreciation and amortisation1012162736
Operating profit after depreciation95110112205444
Other income3471742
Finance costs62663
Profit before one-off items and tax91112114216483
One-off items00−3200
Profit before tax9111282216483
20293356126
728349160356
Other comprehensive income23−70−3
Total comprehensive income748641160353
Net margin13.8%13.5%6.8%15.9%26.6%

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2022Filed 20 MayMar 2023Filed 15 MayMar 2024Filed 13 MayMar 2025Filed 10 JunMar 2026Filed 30 Apr
5225946831,3201,711
5225946741,3101,654
Share capital3636374141
Reserves4865586371,2691,613
Belonging to outside owners of subsidiaries––91057
14217826
129163285202231
7101282742
Total assets6597671,0961,5491,984
2302976007581,103
429470496792881
Net debt−99−55163−241−198
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2022Filed 20 MayMar 2023Filed 15 MayMar 2024Filed 13 MayMar 2025Filed 10 JunMar 2026Filed 30 Apr
−966125118292
1490150165404
−92−3649−70−93
Receivables−41−6430−80−55
Inventories−52−7−35−23−51
Payables33242421−2
Other working capital−3112311216
Tax paid−23−24−24−47−112
Capital spending096280195328
Free cash flow−9−31−155−76−36
−124−33−365−224−266
140−122392614
Dividends paid011111212
Shares bought back00000
Shares issued3000524990
Net change in cash820−115630
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Consolidated, ₹ per share, years to March.Acutaas Chemicals dividend history

₹ per shareMar 2022Filed 20 MayMar 2023Filed 15 MayMar 2024Filed 13 MayMar 2025Filed 10 JunMar 2026Filed 30 Apr
₹10.52₹11.43₹5.84₹19.81₹43.51
As stated that year₹21.03₹22.86₹11.67₹19.81₹43.51
₹10.52₹11.43₹5.83₹19.81₹43.37
₹1.50₹1.50₹1.50₹1.50₹2.50
₹71.67₹81.50₹91.38₹159.97₹201.97
Dividend payout14.3%13.1%25.9%7.7%5.7%
Shareholder yield−8.2%0.3%−1.0%−4.9%0.1%
Market cap at the year end (₹ crore)3,6523,2424,0349,99120,948
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from.

Ratios

Consolidated, years to March.Acutaas Chemicals PE ratio and valuation

RatioMar 2022Filed 20 MayMar 2023Filed 15 MayMar 2024Filed 13 MayMar 2025Filed 10 JunMar 2026Filed 30 Apr
Revenue growth–18.6%16.3%40.3%33.0%
Operating profit growth–16.6%4.8%80.6%107.0%
Net profit growth–15.8%−41.5%229.3%122.2%
Earnings per share growth–8.7%−48.9%239.5%119.6%
14.7%14.9%6.7%16.0%24.0%
–0.3 pts−8.2 pts9.3 pts8.0 pts
From the net margin–−1.2 pts−8.3 pts11.1 pts11.0 pts
From asset turnover–1.3 pts−0.7 pts−0.2 pts−0.1 pts
From borrowing–0.2 pts0.9 pts−1.6 pts−2.8 pts
Return on capital employed18.2%18.5%12.5%15.5%25.6%
Cash conversion−12.0%78.7%257.0%73.8%82.0%
Interest cover14.845.718.933.0136.0
Debt to equity0.000.010.320.010.02
Receivable days11513610510599
Inventory days150131139119149
Payable days15815711910399
Cash conversion cycle, days107111125121149
Working capital days141149132126123
Asset turnover0.790.870.770.760.76
Assets per rupee of net worth1.261.281.471.331.19
Sales per rupee of plant3.282.781.991.992.11
Capital spending to depreciation0.007.8117.467.319.11
Plant being built, % of plant in use1.9%11.5%34.8%25.8%52.5%

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
20.2%
Cash from operations against operating profit
60.8%
Measure5 years3 years
Revenue growth, yearly rate–29.5%
Profit growth, yearly rate–62.3%
Return on equity, average15.3%15.6%
Return on capital employed, average18.0%17.9%
Operating margin, average23.4%25.6%
Net margin, average15.3%16.4%
Asset turnover, average0.790.76
Cash conversion cycle, days, average122131
Interest cover, average49.762.7
Debt to equity, average0.070.11

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations593536292
Cash from investing−1,012−855−266
Cash from financing6335054
Capital spending899803328
Dividends paid463512
Shares bought back000
Shares issued for cash8515510
Borrowings raised–23618
Borrowings repaid2082080

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––364
Altman Z-scorePublished threshold 1.8118.9014.047.8255.0449.02
Beneish M-scorePublished threshold −1.78–−2.07−2.63−1.89−2.01
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–7.1331.0220.1118.69
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––0.891.060.95
Receivables growth less revenue growthOur threshold 0 percentage points–22.09−26.720.44−8.21
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–−15.047.10−19.3226.06
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–1.232.40−0.77−0.76
Assets under construction, years of additionsOur threshold 2 years of additions–0.340.810.762.03
Effective tax ratePublished threshold 17.16 per cent21.3325.7540.5325.7926.18
Tax charged less tax paid, % of profitOur threshold 10 percentage points−3.623.9510.804.173.06
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
9 Dec 2025CARE Ratings Limited (opens in a new tab)Fund-based/Non-fund based-LT/STCARE A+ / CARE A1+Review, Re-affirmStable135
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.